Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2026)
Arcturus Therapeutics Holdings' (ARCT) quarterly EPS (Basic) came in at -$1.99 in Q1 2026, down 283.6% YoY from $1.08 in Q1 2025, and down 87.69% on a QoQ basis from -$1.06 in Q4 2025.
Powered by 
Analysis
Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings (ARCT) has 9 years of EPS (Basic) data on file, last reported at -$1.99 in Q1 2026.
- Quarterly EPS (Basic) fell 283.6% year-over-year to -$1.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.81 (down 51.58% YoY) and the FY2025 annual result came in at -$2.4, up 19.89% from the prior year.
- EPS (Basic) fell to -$1.99 in Q1 2026, from -$1.06 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1911.3 in Q1 2023 to a low of -$1979.2 in Q2 2023.
- A 5-year average of -$40.36 and a median of -$0.82 in 2022 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 98428.19% in 2023, down 242444.51% in 2023.
- Tracing ARCT's EPS (Basic) over 5 years: stood at $4.49 in 2022, then sank by 109.8% to -$0.44 in 2023, then sank by 152.77% to -$1.11 in 2024, then increased by 4.5% to -$1.06 in 2025, then slumped by 87.69% to -$1.99 in 2026.
- The last three EPS (Basic) figures came in at -$1.99 (Q1 2026), -$1.06 (Q4 2025), and -$0.49 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Arcturus Therapeutics Holdings | 449.65 Mn | 258.17 Mn | - | -0.84 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.84 |
| Mar 31, 2026 | -1.02 |
| Dec 31, 2025 | -1.06 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -1.11 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.64 |
| Mar 31, 2024 | -1.00 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.61 |
| Jun 30, 2023 | -1.98 |
| Mar 31, 2023 | 1.91 |
| Dec 31, 2022 | 4.49 |
| Sep 30, 2022 | -1.33 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -1.94 |
| Dec 31, 2021 | -1.43 |
| Sep 30, 2021 | -2.04 |